BioWorld: Onchilles looks for cancer’s Achilles heel with a $7M series A

Lev Becker spent about six years studying how to release neutrophile elastase from human neutrophils so it could select cancer cell types that need killing and ignore non-cancer cells. That research eventually led to a recent publication in Cell and the launch of Onchilles Pharma Inc.

To read the full article, click here.